Longitudinal impact of COVID-19 pandemic on the utilization of hemoglobin A1c testing in outpatients
Clinica Chimica Acta · 2024
DOI: 10.1016/j.cca.2023.117686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2024. Verfasst von Li Zha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States; Present Ad…. Hauptthemen laut MEDLINE: Outpatients, COVID-19. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: During the COVID-19 pandemic, concerns arose about disparate access to health care and laboratory testing. There is limited information about the pandemic's impact on the frequency of diabetic laboratory testing across demographic subgroups (e.g., sex, age over 65 y, and race). METHODS: This retrospective study examined outpatient hemoglobin A1c (HbA1c) testing in a large academic medical center in Upstate New York between March 2019 and March 2021. Multivariate Poisson regression models were used to evaluate the pandemic's effects on HbA1c utilization. RESULTS: Over 190,000 HbA1c results from predominately white (76.1 %) and older (mean age, 60.6 y) outpatients were analyzed. Compared to pre-pandemic time period, the average number of HbA1c tests per patient during COVID time period experienced a small, though significant, drop (1.3 to 1.2; p < 0.001) on aggregate and in outpatients, males, females, and seniors. The modest reduction was not significant by race except for the white seniors (p < 0.001). However, the testing frequency remained within recommendations from the American Diabetes Association for monitoring prediabetic patients and patients with stable glycemic control. CONCLUSION: Given the propensity for healthcare disruptions to widen disparities, it is reassuring that we did not observe a worsening of disparities in rates of HbA1c testing during the COVID-19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States; Present Address: Department of Pathology, Beth Israel Deaconess Medical Center,…
- Division of Endocrinology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States.
- Department of Biostatistics and Computational Biology, University of Rochester, 265 Crittenden Boulevard, CU 420630, Rochester, NY, United States.
- Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States.
- Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States. Electronic address: Victoria_Zhang@urmc.rochester.edu.
Zitieren
APA
Zha, L., MacLeod, S., Love, T., Fortuna, R. J., & Zhang, Y. V. (2024). Longitudinal impact of COVID-19 pandemic on the utilization of hemoglobin A1c testing in outpatients. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2023.117686
Vancouver
Zha L, MacLeod S, Love T, Fortuna RJ, Zhang YV. Longitudinal impact of COVID-19 pandemic on the utilization of hemoglobin A1c testing in outpatients. Clinica Chimica Acta. 2024. doi:10.1016/j.cca.2023.117686
BibTeX
@article{Zha2024,
author = {Zha, Li and MacLeod, Sara and Love, Tanzy and Fortuna, Robert J and Zhang, Y Victoria},
title = {Longitudinal impact of COVID-19 pandemic on the utilization of hemoglobin A1c testing in outpatients},
journal = {Clinica Chimica Acta},
year = {2024},
doi = {10.1016/j.cca.2023.117686}
}
EUVIMED